BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 62 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $994,000 | -71.6% | 16,396 | -79.7% | 0.22% | -42.9% |
| Q4 2017 | $3,497,000 | -44.6% | 80,710 | -40.5% | 0.39% | -41.8% |
| Q3 2017 | $6,311,000 | +16.3% | 135,657 | +23.7% | 0.67% | +18.7% |
| Q2 2017 | $5,428,000 | -19.6% | 109,644 | -11.0% | 0.57% | -22.8% |
| Q1 2017 | $6,749,000 | -4.8% | 123,152 | -3.2% | 0.74% | +4.4% |
| Q4 2016 | $7,089,000 | +25.5% | 127,277 | +2.9% | 0.70% | +20.3% |
| Q3 2016 | $5,649,000 | +133.4% | 123,702 | +163.7% | 0.59% | +105.6% |
| Q2 2015 | $2,420,000 | -50.1% | 46,903 | -62.1% | 0.28% | -45.6% |
| Q1 2015 | $4,845,000 | +45.2% | 123,764 | +43.2% | 0.52% | +30.7% |
| Q4 2014 | $3,337,000 | +97.6% | 86,402 | +80.5% | 0.40% | +124.0% |
| Q3 2014 | $1,689,000 | -7.4% | 47,857 | -29.3% | 0.18% | +1.7% |
| Q2 2014 | $1,824,000 | -26.8% | 67,657 | -29.7% | 0.18% | -30.4% |
| Q1 2014 | $2,493,000 | -19.1% | 96,200 | -32.4% | 0.25% | -7.0% |
| Q4 2013 | $3,082,000 | +56.2% | 142,215 | +40.4% | 0.27% | +17.7% |
| Q3 2013 | $1,973,000 | – | 101,325 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |